TITLE

Pharmacological Profile of SSRIs and SNRIs in the Treatment of Eating Disorders

AUTHOR(S)
Capasso, Anna; Petrella, Claudio; Milano, Walter
PUB. DATE
January 2009
SOURCE
Current Clinical Pharmacology;Jan2009, Vol. 4 Issue 1, p78
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Bulimia Nervosa (BN) and Binge Eating Disorder (BED) are some of the most common eating disorders (ED) in industrialized societies, characterized by uncontrolled binge eating and self-induced purging or other compensatory behaviours aiming to prevent body weight gain. It has been suggested that reduced serotonergic and noradrenergig tone triggers some of the cognitive and mood disturbances associated with ED. In fact in the active phase of ED the concentration of serotonin and noradrenaline in cerebral fluid is reduced. For these reasons, the pharmacologic treatment of ED consists mainly of selective serotonin reuptake inhibitors (SSRIs) or selective noradrenaline reuptake inhibitors (SNRIs) . At present, the physiologic basis of this disorder are not yet completely understood. In this review we evaluate several randomized controlled trials to compare the efficacy of several SSRIs and SNRIs in patients with a diagnosis of ED as defined by the fourth edition of the Diagnostic and Statistical Manual of Mental Disorders [DSM IV]) These findings indicate that both SSRIs and SNRIs are well tolerated and reduce effectively the bulimic crisis and purging episodes in patients with ED.
ACCESSION #
60435372

 

Related Articles

  • Drug Therapy for Patients with Eating Disorders. Mitchell, J.E.; de Zwaan, M.; Roerig, J.L. // Current Drug Targets - CNS & Neurological Disorders;Feb2003, Vol. 2 Issue 1, p17 

    The purpose of this article is to review the psychopharmacology treatment literature for patients with eating disorders including bulimia nervosa, anorexia nervosa and binge eating disorder. The best-developed treatment literature concerns bulimia nervosa, which has been studied now in several...

  • Bulimia Nervosa in DSM-5. Wolfe, Barbara E.; Hannon-Engel, Sandra L.; Mitchell, James E. // Psychiatric Annals;Nov2012, Vol. 42 Issue 11, p406 

    The article focuses on bulimia nervosa (BM), a disorder introduced as bulimia in the Diagnostic and Statistical Manual of Mental Disorders (DSM), Third Edition, 1. It discusses the frequency of binge eating, the subthreshold criteria, and the number of patients diagnosed. The two primary...

  • Do you need to read this article? Try this quiz.  // New Zealand Doctor;5/4/2005, p19 

    Presents a quiz about eating disorders. Recovery of patients with eating disorders; Description of bulimia nervosa; Efficacy of selective serotonin reuptake inhibitors in treating anorexia.

  • Duloxetine.  // Reactions Weekly;2/27/2010, Issue 1290, p20 

    The article describes the case of a 37-year-old woman who developed binge eating while receiving treatment with duloxetine for major depressive disorder.

  • How to beat binge eating. Cohen, Sharon; Doheny, Kathleen; Scotch, Allison Winn // Shape;Oct2003, Vol. 23 Issue 2, p28 

    Presents tips to control binge eating behavior, from the clinical co-director of the Eating Disorders Unit at the New York State Psychiatric Institute in New York City.

  • Sibutramine Treatment for Binge-Eating Disorder. Miller, Karl E. // American Family Physician;5/1/2004, Vol. 69 Issue 9, p2225 

    Deals with the use of sibutramine to treat binge-eating disorder. Differentiation of the characteristic between binge-eating disorder and bulimia nervosa; Information on the high rate of comorbid psychiatric disorders among binge-eating patients; Benefits of serotonin reuptake inhibitors in...

  • Treating Bulimia Nervosa in a Primary Care Setting.  // Eating Disorders Review;Mar/Apr2004, Vol. 15 Issue 2, p6 

    Discusses the different treatment approaches for the eating disorder, bulimia nervosa, in a primary care setting. Development of self-help programs based on the principles of cognitive behavior therapy; Examination on the use of serotonin reuptake inhibitor; Benefits of treatment approaches on...

  • Treating Night Eating Syndrome with Sertraline.  // Eating Disorders Review;Jul/Aug2006, Vol. 17 Issue 4, p7 

    The article reports on the study on the effective treatment of night eating syndrome with sertraline, a selective serotonin inhibitor. John P. O'Reardon and colleagues from the University of Pennsylvania diagnosed 34 patients with night eating syndrome and found that those treated with...

  • A Comparative Study between Three Different SSRIs in the Treatment of Bulimia Nervosa. Milano, W.; De Rosa, M.; Milano, L.; Riccio, A.; Sanseverino, B.; Capasso, A. // Current Neurobiology;Oct2013, Vol. 4 Issue 1/2, p39 

    Bulimia Nervosa (BN) is one of the most common eating disorders in industrialized societies, characterized by uncontrolled binge eating and self-induced purging or other compensatory behaviours aiming to prevent body weight gain. It has been suggested that reduced serotonergic tone triggers some...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics